ArticleEye (London, England)2026
Prevalence and associations of central serous chorioretinopathy in a population aged 50+ years. The Beijing Eye Study.
Article in Eye (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reduced AI-based sex classification performance in clinically unaffected fellow eyes of patients with polypoidal choroidal vasculopathy: comparison with central serous chorioretinopathy and controls.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo assess prevalence and associations of active central serous chorioretinopathy (CSC) and inactive CSC/pachychoroid pigment epitheliopathy (PPE) in a general population aged 50+ years.
methodsUsing optical coherent tomographic images, we assessed CSC lesions in participants of the population-based Beijing Eye Study. We differentiated between active CSC with subretinal fluid, and inactive CSC/PPE with retinal pigment epithelium irregularities and dilated large choroidal vessels and without subretinal fluid.
resultsOut of 6551 eyes, CSC/PPE was detected in 98 eyes (70 participants; 60 (86%) men) (prevalence: 1.5%; 95%CI: 1.1, 1.9), with active CSC (with/without inactive CSC/PPE) in 52 eyes (53%) and inactive CSC/PPE (with/without an active component) in 66 eyes (67%). CSC location was only foveal in 21 (21%) eyes, only extrafoveal in 44 (45%) eyes, and mixed in 33 (34%) eyes. CSC occurred bilaterally in 28 patients (56 (57%) eyes). Both eyes of all CSC patients (also those with unilateral CSC) showed markedly dilated large choroidal vessels. CSC lesion number ranged between 1 and 13 (mean:2.5 ± 2.2) per eye. Higher CSC prevalence was associated with younger age (OR: 0.95; 95%CI: 0.91, 0.99; P = 0.01), male sex (OR: 4.16; 95% CI: 1.92, 9.02; P < 0.001), thicker subfoveal choroid (OR: 1.004; 95% CI: 1.001, 1.007; P = 0.01), and higher prevalences of retinal outer nuclear layer thinning (OR: 4.08; 95% CI: 1.25, 13.3; P = 0.02), intraretinal hyperreflective foci (iHRFs) beyond the ellipsoid zone (OR: 7.11; 95% CI: 3.21, 15.8; P < 0.001), macular hypopigmentations (OR: 1.55; 95% CI: 1.30, 1.85; P < 0.001), and incomplete retinal pigment epithelium and outer retinal atrophy (iRORA) (OR: 12.3; 95% CI: 2.97, 51.1; P < 0.001).
conclusionsActive CSC and inactive CSC/PPE together were relatively frequent in a general population consisting of Han Chinese from the Beijing region and aged 50+ years. They occurred often multifocal and were often extrafoveally located.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.